Adalimumab biosimilars and access barriers in dermatology.
- DOI
- 10.1016/j.jaad.2026.06.119
- Published
- 2026 Oct
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.06.119,
title = {Adalimumab biosimilars and access barriers in dermatology.},
author = {Alomary SA and Baker NJ and Alladeen A and Alkiswani H and Chovatiya R and Dasilva DR and Lewitt GM and Lio PA and Nguyen H and Song EJ and Taylor SC and Mollanazar NK},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.06.119},
url = {https://doi.org/10.1016/j.jaad.2026.06.119}
}RIS
TY - JOUR TI - Adalimumab biosimilars and access barriers in dermatology. AU - Alomary SA AU - Baker NJ AU - Alladeen A AU - Alkiswani H AU - Chovatiya R AU - Dasilva DR AU - Lewitt GM AU - Lio PA AU - Nguyen H AU - Song EJ AU - Taylor SC AU - Mollanazar NK PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.06.119 UR - https://doi.org/10.1016/j.jaad.2026.06.119 ER -
APA
SA, A., NJ, B., A, A., H, A., R, C., DR, D., GM, L., PA, L., H, N., EJ, S., SC, T., & NK, M. (2026). Adalimumab biosimilars and access barriers in dermatology.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.06.119
Source records
- pubmed · retrieved 2026-09-25T07:02:13.520Z
- europe-pmc · retrieved 2026-09-25T07:02:13.515Z